AMBER TOMLINSON: Open Payments
NPI 1487198974 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,286 in 115 payments from 21 companies in 2025. Trend: 2023 $2,553 · 2024 $2,294 · 2025 $2,286
Food & beverage: $2,286
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 12 | $328 |
| PFIZER INC. | 15 | $267 |
| ABBVIE INC. | 16 | $237 |
| Dexcom, Inc. | 12 | $185 |
| AstraZeneca Pharmaceuticals LP | 6 | $176 |
| Sumitomo Pharma America, Inc. | 7 | $151 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $150 |
| Corcept Therapeutics | 3 | $147 |
| Novo Nordisk Inc | 8 | $136 |
| Lilly USA, LLC | 4 | $92 |
Products named: Veozah, Dexcom G6 Transmitter, ELIQUIS, GEMTESA, Kerendia, Korlym, BREZTRI, JARDIANCE.
Industry payments across GA — which companies pay providers there.
